Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
ARENA PHARMACEUTICALS INC has filed 1,425 SEC EDGAR filings since 28 Apr 2000

SEC filing history

Showing 451-475 of 822 matching filings.

Per page
25
Current page
19
SC 13G/A File 005-59397

SEC SCHEDULE 13G

Filing date
11 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-59397

SC 13G/A filing

Filing date
10 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-59397

SC 13G/A filing

Filing date
25 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

8-K

Filing date
12 Jan 2016
Reporting date
12 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Dec 2015
Reporting date
16 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
18 Dec 2015
Reporting date
16 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Dec 2015
Reporting date
15 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Dec 2015
Reporting date
15 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Dec 2015
Reporting date
15 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Dec 2015
Reporting date
15 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Dec 2015
Reporting date
15 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

8-K

Filing date
01 Dec 2015
Reporting date
30 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

8-K

Filing date
10 Nov 2015
Reporting date
10 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

8-K

Filing date
29 Oct 2015
Reporting date
29 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

8-K

Filing date
27 Oct 2015
Reporting date
27 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

8-K

Filing date
05 Oct 2015
Reporting date
05 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

8-K

Filing date
05 Aug 2015
Reporting date
05 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

8-K

Filing date
29 Jul 2015
Reporting date
29 Jul 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
13 Jul 2015
Reporting date
10 Jul 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-31161

8-K

Filing date
09 Jul 2015
Reporting date
09 Jul 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jun 2015
Reporting date
12 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jun 2015
Reporting date
12 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jun 2015
Reporting date
12 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .